Veterans Affairs Greater Los Angeles Healthcare System, University of California at Los Angeles, and South California Research Center for Alcoholic Liver and Pancreatic Diseases, California; Beijing Hospital, Beijing, China.
Veterans Affairs Greater Los Angeles Healthcare System, University of California at Los Angeles, and South California Research Center for Alcoholic Liver and Pancreatic Diseases, California;
Am J Physiol Gastrointest Liver Physiol. 2014 Sep 1;307(5):G550-63. doi: 10.1152/ajpgi.00432.2013. Epub 2014 Jul 17.
Understanding the regulation of death pathways, necrosis and apoptosis, in pancreatitis is important for developing therapies directed to the molecular pathogenesis of the disease. Protein kinase Cε (PKCε) has been previously shown to regulate inflammatory responses and zymogen activation in pancreatitis. Furthermore, we demonstrated that ethanol specifically activated PKCε in pancreatic acinar cells and that PKCε mediated the sensitizing effects of ethanol on inflammatory response in pancreatitis. Here we investigated the role of PKCε in the regulation of death pathways in pancreatitis. We found that genetic deletion of PKCε resulted in decreased necrosis and severity in the in vivo cerulein-induced pancreatitis and that inhibition of PKCε protected the acinar cells from CCK-8 hyperstimulation-induced necrosis and ATP reduction. These findings were associated with upregulation of mitochondrial Bak and Bcl-2/Bcl-xL, proapoptotic and prosurvival members in the Bcl-2 family, respectively, as well as increased mitochondrial cytochrome c release, caspase activation, and apoptosis in pancreatitis in PKCε knockout mice. We further confirmed that cerulein pancreatitis induced a dramatic mitochondrial translocation of PKCε, suggesting that PKCε regulated necrosis in pancreatitis via mechanisms involving mitochondria. Finally, we showed that PKCε deletion downregulated inhibitors of apoptosis proteins, c-IAP2, survivin, and c-FLIPs while promoting cleavage/inactivation of receptor-interacting protein kinase (RIP). Taken together, our findings provide evidence that PKCε activation during pancreatitis promotes necrosis through mechanisms involving mitochondrial proapoptotic and prosurvival Bcl-2 family proteins and upregulation of nonmitochondrial pathways that inhibit caspase activation and RIP cleavage/inactivation. Thus PKCε is a potential target for prevention and/or treatment of acute pancreatitis.
了解胰腺炎中细胞死亡途径(坏死和细胞凋亡)的调控对于开发针对该疾病分子发病机制的治疗方法非常重要。蛋白激酶 Cε(PKCε)先前已被证明可调节胰腺炎中的炎症反应和酶原激活。此外,我们还证明乙醇特异性激活胰腺腺泡细胞中的 PKCε,并且 PKCε介导了乙醇对胰腺炎炎症反应的敏化作用。在这里,我们研究了 PKCε 在胰腺炎中细胞死亡途径调控中的作用。我们发现,PKCε 的基因缺失导致体内 Cerulein 诱导的胰腺炎中坏死和严重程度降低,并且 PKCε 的抑制可保护胰腺腺泡细胞免受 CCK-8 过度刺激诱导的坏死和 ATP 减少。这些发现与线粒体 Bak 和 Bcl-2/Bcl-xL 的上调相关,Bcl-2 家族中的促凋亡和抗凋亡成员分别上调,以及线粒体细胞色素 c 释放、半胱天冬酶激活和凋亡增加在 PKCε 基因敲除小鼠的胰腺炎中。我们进一步证实 Cerulein 胰腺炎诱导 PKCε 发生剧烈的线粒体易位,表明 PKCε 通过涉及线粒体的机制调节胰腺炎中的坏死。最后,我们表明 PKCε 的缺失下调了凋亡抑制蛋白 c-IAP2、survivin 和 c-FLIPs,同时促进了受体相互作用蛋白激酶(RIP)的切割/失活。总之,我们的研究结果提供了证据表明,胰腺炎期间 PKCε 的激活通过涉及线粒体促凋亡和抗凋亡 Bcl-2 家族蛋白以及上调抑制半胱天冬酶激活和 RIP 切割/失活的非线粒体途径来促进坏死。因此,PKCε 是预防和/或治疗急性胰腺炎的潜在靶点。